Evidence map›Paper›PMID 33444097›Full record

ReviewJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2021

Understanding the brain uptake and permeability of small molecules through the BBB: A technical overview.

Ekram Ahmed Chowdhury, Behnam Noorani, Faleh Alqahtani, Aditya Bhalerao, Snehal Raut, Farzane Sivandzade, Luca Cucullo

Open access · greenAbstract readReview
In one paragraph

Review in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 64 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Frontiers in toxicology · 2026
    Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Polysaccharides fromHeliyon · 2024
    Article
  17. Investigating the Potential of Essential Oils fromPlants (Basel, Switzerland) · 2024
    Article
  18. Review
  19. Article
  20. Not open and shut: Complex and prolonged blood-brain barrier responses after stroke.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Ekram Ahmed ChowdhuryDepartment of Pharmaceutical Sciences, Texas Tech University Health Sciences Center, Amarillo, USA.
Behnam NooraniDepartment of Pharmaceutical Sciences, Texas Tech University Health Sciences Center, Amarillo, USA.
Faleh AlqahtaniDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Aditya BhaleraoDepartment of Foundational Medical Studies, Oakland University William Beaumont School of Medicine, Rochester, USA.
Snehal RautDepartment of Pharmaceutical Sciences, Texas Tech University Health Sciences Center, Amarillo, USA.
Farzane SivandzadeDepartment of Foundational Medical Studies, Oakland University William Beaumont School of Medicine, Rochester, USA.
Luca CuculloDepartment of Foundational Medical Studies, Oakland University William Beaumont School of Medicine, Rochester, USA.ORCID 0000-0002-2827-7162
Oakland University · USTexas Tech University · USKing Saud University · SA

Funding

Testing tobacco smoke toxicity at the blood-brain barrierR01DA029121 · NIDA · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI ABBRUSCATO, THOMAS J, CUCULLO, LUCA · 2011 to 2021
$3.6M
Repurposing Metformin to Offset Stroke Risk and Injury in Comorbid Populations of SmokersR01NS117906 · NINDS · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI ABBRUSCATO, THOMAS J, CUCULLO, LUCA · 2020 to 2024
$2.9M
Blood and Brain Based Biomarkers of Injury to Assess the Cerebrovascular Impact of Emerging Alternatives to Classic Cigarette ProductsR01DA049737 · NIDA · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI ABBRUSCATO, THOMAS J, CUCULLO, LUCA · 2019 to 2021
$1.4M
NIDA NIH HHS R01 DA029121NIDA NIH HHS R01 DA049737NINDS NIH HHS R01 NS117906
6 · The paper itself

Abstract

The brain is the most important organ in our body requiring its unique microenvironment. By the virtue of its function, the blood-brain barrier poses a significant hurdle in drug delivery for the treatment of neurological diseases. There are also different theories regarding how molecules are typically effluxed from the brain. In this review, we comprehensively discuss how the different pharmacokinetic techniques used for measuring brain uptake/permeability of small molecules have evolved with time. We also discuss the advantages and disadvantages associated with these different techniques as well as the importance to utilize the right method to properly assess CNS exposure to drug molecules. Even though very strong advances have been made we still have a long way to go to ensure a reduction in failures in central nervous system drug development programs.

Indexed as

AnimalsBlood-Brain BarrierBrainHumansKineticsNervous System DiseasesPermeabilitySmall Molecule LibrariesSucroseSmall Molecule LibrariesSucroseBlood-brain barrierbrain vascular volume correctionpermeabilitypharmacokineticssmall molecules

Identifiers

PMID33444097
PMCPMC8327119
OpenAlexW3120430648

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.